State Street Exits Telix Pharmaceuticals Stake
Company Announcements

State Street Exits Telix Pharmaceuticals Stake

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

State Street Corporation and its subsidiaries have ceased to be substantial holders in Telix Pharmaceuticals Limited as of August 12, 2024. This change in financial interest has been duly noted in the regulatory forms required by the Corporations Act 2001. The details of the change, including the nature of the change and the persons and votes affected, have been recorded and submitted on August 14, 2024.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTelix announces Cardinal Health as U.S. commercial distributor for Zircaix
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Seeks New Shares Quotation
TheFlyTelix says IPAX-1 Phase I study published in Neuro-Oncology Advances
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App